Comparison of the NCI Open Database with Seven Large Chemical Structural Databases-Reference-Cited by-同舟云学术

Comparison of the NCI Open Database with Seven Large Chemical Structural Databases

Published:2001-05-01 Issue:3 Volume:41 Page:702-712
ISSN:0095-2338
Container-title:Journal of Chemical Information and Computer Sciences
language:en
Short-container-title:J. Chem. Inf. Comput. Sci.

Author:

Voigt Johannes H.¹,Bienfait Bruno¹,Wang Shaomeng¹,Nicklaus Marc C.¹

Affiliation:

1. Laboratory of Medicinal Chemistry, Center for Cancer Research, National Cancer Institute, National Institutes of Health, NCI at Frederick, 376 Boyles Street, Frederick, Maryland 21702, and Structural Biology and Cancer Drug Discovery Program, Lombardi Cancer Center & Departments of Oncology and Neuroscience, Georgetown University Medical Center, 3970 Reservoir Road, Washington, DC 20007

Publisher

American Chemical Society (ACS)

Subject

Computational Theory and Mathematics,Computer Science Applications,Information Systems,General Chemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ci000150t

Reference31 articles.

1. The NCI Drug Information System. 2. DIS pre-registry

2. The NCI Drug Information System. 3. The DIS chemistry module

3. The NCI Drug Information System. 4. Inventory and shipping modules

4. The NCI Drug Information System. 6. System maintenance

Cited by 193 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insights into coordination and ligand trends of lanthanide complexes from the Cambridge Structural Database;Scientific Reports;2024-05-17

2. Consensus Pharmacophore Strategy For Identifying Novel SARS-Cov-2 M^pro Inhibitors from Large Chemical Libraries;Journal of Chemical Information and Modeling;2024-03-12

3. Application of established computational techniques to identify potential SARS-CoV-2 Nsp14-MTase inhibitors in low data regimes;Digital Discovery;2024

4. Identification of selective 5-LOX and FLAP inhibitors as novel anti-inflammatory agents by ligand-based virtual screening;European Journal of Medicinal Chemistry;2024-01

5. Drug Discovery in Low Data Regimes: Leveraging a Computational Pipeline for the Discovery of Novel SARS-CoV-2 Nsp14-MTase Inhibitors;2023-10-04